Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. [electronic resource]
Producer: 20180418Description: 582-587 p. digitalISSN:- 1095-9203
- Adult
- Aged
- Antigen Presentation
- Antigens, Neoplasm -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- CTLA-4 Antigen -- antagonists & inhibitors
- Cancer Vaccines -- immunology
- Cohort Studies
- Genetic Carrier Screening
- Histocompatibility Antigens Class I -- chemistry
- Humans
- Immunotherapy -- methods
- Melanoma -- genetics
- Middle Aged
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Protein Conformation
- Skin Neoplasms -- genetics
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.